Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,221 | -38,719 | -36,572 | -29,524 | -13,886 |
| Depreciation Amortization | 591 | 586 | 582 | 561 | 3,417 |
| Other Working Capital | -522 | -203 | -28 | 283 | 2,132 |
| Other Operating Activity | 42,343 | 34,837 | 33,688 | 27,857 | 5,569 |
| Operating Cash Flow | $-4,809 | $-3,499 | $-2,330 | $-823 | $-2,769 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | -5 | N/A | N/A | N/A |
| Investing Cash Flow | $-26 | $-5 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -113 | -86 | -49 | -13 | -308 |
| Common Stock Issued | 280 | 280 | 280 | 280 | 3,147 |
| Other Financing Activity | 5,026 | 4,398 | 2,723 | 608 | 0 |
| Financing Cash Flow | $5,193 | $4,592 | $2,954 | $874 | $2,839 |
| Beginning Cash Position | 70 | 70 | 70 | 70 | N/A |
| End Cash Position | 429 | 1,158 | 694 | 121 | 70 |
| Net Cash Flow | $359 | $1,088 | $624 | $51 | $70 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,809 | -3,499 | -2,330 | -823 | -2,769 |
| Capital Expenditure | -26 | -5 | N/A | N/A | N/A |
| Free Cash Flow | -4,835 | -3,504 | -2,330 | -823 | -2,769 |